Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Atea Pharmaceuticals Inc
About AVIR
Atea Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on discovering, developing and commercializing oral antiviral therapies to address the unmet medical needs of patients with serious viral infections. Its product candidate pipeline includes the regimen of bemnifosbuvir and ruzasvir which has the potential to improve the current standard of care (SOC) for the treatment of patients with hepatitis C virus (HCV) infection and AT-587 which has the potential to be the first direct-acting antiviral (DAA) for the treatment of patients, particularly immunocompromised patients, with chronic hepatitis E virus (HEV) infection. The global HCV Phase III program it is conducting consists of two randomized, open-label studies: C-BEYOND which has clinical trial sites in the United States and Canada, and C-FORWARD which has clinical trial sites in countries outside of North America. AT-587 has demonstrated potent nanomolar antiviral activity against HEV in vitro.
Find out what a historical investment in Atea Pharmaceuticals Inc would be worth today using our AVIR stock calculator.
Market Capitalisation
$348.92M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
237.44K
High today
$4.46
Low today
$4.36
Open price
$4.38
52-week high
$6.45
52-week low
$2.78
Ready to start your investing journey with Stake?
Open an accountHow do I buy AVIR shares in Australia?
Buying AVIR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Atea Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AVIR
What is the ticker symbol of Atea Pharmaceuticals Inc?
The ticker symbol for Atea Pharmaceuticals Inc is AVIR.
How much is one share of AVIR?
One share of AVIR is valued at $4.39 as of 10 June 2026.
What is the market capitalisation of Atea Pharmaceuticals Inc AVIR?
As of 10 June 2026 Atea Pharmaceuticals Inc has a market cap of $348.92M.
What is the 52-week high for Atea Pharmaceuticals Inc stock?
The Atea Pharmaceuticals Inc 52-week high stock price is $6.45.
What is the 52-week low for Atea Pharmaceuticals Inc stock?
The Atea Pharmaceuticals Inc 52-week low stock price is $2.78.
Can I buy AVIR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AVIR shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AVIR on Stake
- Buy AVIR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AVIR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AVIR related stocks